Uscom Limited (AU:UCM)
ASX:UCM
Want to see AU:UCM full AI Analyst Report?
UCM Stock Chart & Stats
AU$0.01
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.01
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.02
Previous CloseN/A
Volume140.68K
Average Volume (3M)3.23K
Market Cap
AU$3.12M
Enterprise ValueAU$4.42M
Total Cash (Recent Filing)AU$966.66K
Total Debt (Recent Filing)AU$2.26M
Price to Earnings (P/E)―
Beta-1.89
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding260,147,130
10 Day Avg. Volume0
30 Day Avg. Volume3,233
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-76.24
Price to Sales (P/S)1.13
P/FCF Ratio-1.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product OfferingUscom's focus on innovative non-invasive monitoring devices, like the Uscom 1A, positions it well in the growing healthcare technology sector, providing a competitive edge in improving patient outcomes.
Recurring RevenueThe company's strategy of generating recurring revenue through service contracts and training provides a stable income stream, enhancing financial predictability and customer retention.
Operational EfficiencyA high gross profit margin indicates strong operational efficiency, suggesting that the company can maintain profitability on its core products despite overall financial challenges.
Bears Say
Financial InstabilityThe negative equity and poor debt-to-equity ratio highlight potential solvency issues, which could limit the company's ability to invest in growth and innovation.
Revenue DeclineA significant decline in revenue growth indicates challenges in market demand or competitive pressures, potentially impacting long-term sustainability and market position.
Cash Flow ChallengesNegative operating cash flow suggests that the company struggles to generate sufficient cash from operations, which could hinder its ability to fund ongoing operations and strategic initiatives.
Uscom Limited News
UCM FAQ
What was Uscom Limited’s price range in the past 12 months?
Uscom Limited lowest share price was AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is Uscom Limited’s market cap?
Uscom Limited’s market cap is AU$3.12M.
When is Uscom Limited’s upcoming earnings report date?
Uscom Limited’s upcoming earnings report date is Aug 13, 2026 which is in 64 days.
How were Uscom Limited’s earnings last quarter?
Uscom Limited released its earnings results on Feb 27, 2026. The company reported AU$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.003.
Is Uscom Limited overvalued?
According to Wall Street analysts Uscom Limited’s price is currently Overvalued.
Does Uscom Limited pay dividends?
Uscom Limited does not currently pay dividends.
What is Uscom Limited’s EPS estimate?
Uscom Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Uscom Limited have?
Uscom Limited has 260,147,130 shares outstanding.
What happened to Uscom Limited’s price movement after its last earnings report?
Uscom Limited reported an EPS of AU$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Uscom Limited?
Currently, no hedge funds are holding shares in AU:UCM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Uscom Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
AU:UCM Sentiment 50%
Sector Average ―
Sector Average ―
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-358.43%
Trailing 12-Months
Asset Growth
-90.07%
Trailing 12-Months
Company Description
Uscom Limited
Globally, Uscom Limited specializes in the creation, production, and distribution of non-intrusive medical instruments for assessing heart and lung health. Its product portfolio includes the USCOM 1A, a device utilizing Doppler ultrasound to non-invasively assess hemodynamic and cardiovascular performance. Also available is the BP+, a central blood pressure monitor employing supra-systolic oscillometry to gauge blood pressure and its waveforms both centrally (at the heart) and peripherally (in the arm). The company also produces the SpiroSonic, an ultrasound-based multi-path system for evaluating pulmonary function. Further expanding its offerings, Uscom presents the SpiroSonic AIR, a digital multipath ultrasonic spirometer featuring an integrated viral disinfection system capable of neutralizing pathogens like COVID and tuberculosis, alongside other respiratory equipment. Uscom's solutions are delivered to hospitals and various healthcare facilities via a broad network of distribution alliances. Established in 1999, the firm initially operated as Uscom Pty Limited before adopting the name Uscom Limited in October 2003. Its main corporate office is situated in Sydney, Australia.
Technical Analysis
Impedimed Limited
―
Cyclopharm Limited
―
4DMedical Ltd
―
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―
Options Prices
Currently, No data available
---